StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) income statement

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)

Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –

Innoviva, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
74.5%
Operating margin
38.8%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
15.44
Debt to equity
0.23
Debt to assets
16.8%
Cash to current liabilities
1162.1%

Valuation

P/E ratio
9.3
Price to sales
3.03
Price to book
1.17
Dividend yield
–

See a number that looks wrong?